The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis.

  title={The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis.},
  author={Monika Raisova and Amir M. Hossini and J{\"u}rgen Eberle and Christian Riebeling and Thomas Wieder and Isrid Sturm and Peter T. Daniel and Constantin E. Orfanos and Christoph C. Geilen},
  journal={The Journal of investigative dermatology},
  volume={117 2},
Defective cytochrome c release and the resulting loss of caspase-3 activation was recently shown to be essential for the susceptibility of human melanoma cells to CD95/Fas-induced apoptosis. Cytochrome c release from mitochondria is regulated by the relative amounts of apoptosis-promoting and apoptosis-inhibiting Bcl-2 proteins in the outer membrane of these organelles. The assignment of Bax/Bcl-2 ratios by quantitative Western blotting in 11 melanoma cell populations revealed a relation to the… 

Figures and Tables from this paper

Disruption of the VDAC2–Bak interaction by Bcl-xS mediates efficient induction of apoptosis in melanoma cells

A notable interaction between Bcl-xS and VDAC2 in melanoma cells was identified, which was proven in reciprocal coimmunoprecipitation analyses and suggested a new proapoptotic mechanism.

Release Differential Regulation of Cytochrome c and Smac / DIABLO ( TRAIL )-induced Mitochondrial Disruption and Apoptosis : Tumor Necrosis Factor-related Apoptosis-inducing Ligand Involvement of Proapoptotic Molecules Bax and Bak in Updated

The data suggest that Bax and Bak differentially regulate the release of cytochrome c and Smac/DIABLO from mitochondria, and SmAC/DiaBLO can be used to sensitize cells that are deficient in Bax or Bak genes, or resistant to TRAIL.

Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-xL in a strictly caspase-3-dependent manner in human carcinoma cells

Smac is capable of circumventing defects in mitochondrial apoptosis signaling such as loss of Bax or overexpression of Bcl-xL that are frequently observed in tumor cells resistant to anticancer therapy and appears to be a promising therapeutic target in anticancer treatment.

Down-Regulation of Mcl-1 by Small Interfering RNA Sensitizes Resistant Melanoma Cells to Fas-Mediated Apoptosis

This study identifies mitogen-activated protein kinase/ERK/Mcl-1 as an important survival signaling pathway in the resistance of melanoma cells to Fas-mediated apoptosis and suggests that its targeting may contribute to the elimination of melan cancer tumors by the immune system.

Caspase-independent induction of apoptosis in human melanoma cells by the proapoptotic Bcl-2-related protein Nbk / Bik

The data indicate the high potential of Nbk / Bik in regulating apoptosis in melanoma by a caspase-independent pathway and may corroborate the potency of novel antimelanoma strategies based on activation of BH3-only proteins such as NbK / Bk.

Sensitization of melanoma cells for TRAIL-induced apoptosis by BMS-345541 correlates with altered phosphorylation and activation of Bax

Modulation of Bax phosphorylation appeared as tightly related to TRAIL sensitivity/resistance in melanoma cells, and therapeutic strategies may be considered.

Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells

It is shown by measurement of mitochondrial permeability transition, cytochrome c release, activation of caspase-3 and DNA fragmentation that ceramide-induced apoptosis is marginal in Bax-negative DU 145 cells, and it is concluded that Bax is a key activator of Ceramide-mediated death pathways.

Overexpression of Bax induces apoptosis and enhances drug sensitivity of hepatocellular cancer-9204 cells.

Overexpression of Bax not only induces apoptosis, but also sensitizes HCC-9204 cells to cell death induced by adriamycin.

Proapoptotic and Antiapoptotic Proteins of the Bcl-2 Family Regulate Sensitivity of Pancreatic Cancer Cells Toward Gemcitabine and T-Cell–mediated Cytotoxicity

Investigation of the role of the mitochondrial proteins B cl-2, Bcl-xL, and Bax for sensitization of pancreatic carcinoma cells toward T-cell–mediated cytotoxicity alone and in combination with Gem determined sensitivity towards both Gem and CTL-mediated toxicity.



Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells.

Perturbance of mitochondrial function constitutes a central coordinating event in drug-induced cell death and is demonstrated to be a critical role for mitochondria in apoptosis.

Anti-cell death activity promotes pulmonary metastasis of melanoma cells

It is demonstrated that prolonged cell survival is a crucial factor to promote metastasis of melanoma, thereby contributing to tumor progression.

Loss of the bcl-2 phosphorylation loop domain increases resistance of human leukemia cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis.

It is demonstrated that deletion of the Bcl-2 phosphorylation loop domain increases resistance of U937 leukemia cells to paclitaxel-mediated mitochondrial damage and apoptosis and suggested that factors other than, or in addition to,osphorylation contribute to B cl-2-related cytoprotectivity against pac litaxel in this model system.

Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo

It is concluded that in ALL relapse a severe disturbance of apoptotic pathways occurs, both at the level of Bax expression and caspase-3 activation.

Expression of apoptosis regulators in cutaneous malignant melanoma.

  • L. TangV. Tron M. Trotter
  • Biology, Medicine
    Clinical cancer research : an official journal of the American Association for Cancer Research
  • 1998
It is concluded that the apoptosis inhibitors Bcl-XL or Mcl-1, alone or in combination, may circumvent the normal cell death pathway, contributing to the pathogenesis and treatment resistance in metastatic MM.

Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.

It is demonstrated that a temperature-sensitive p53 induces temperature-dependent decreases in the expression of the apoptosis-suppressing gene bcl-2 in the murine leukemia cell M1, while simultaneously stimulating increases in theexpression of bax, a gene which encodes a dominant-inhibitor of the Bcl-1 protein.

Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.

It is proposed that dysregulation of apoptosis might contribute to the pathogenesis of breast cancer at least in part due to an imbalance between members of the bcl-2 gene family.

Cytotoxic drugs and the CD95 pathway

Cytotoxic drugs commonly used in chemotherapy of leukemia and solid tumors have been shown to primarily act by inducing apoptosis in sensitive target cells. Apoptosis may involve activation of

Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors.

Because BA exhibited significant antitumor activity on patients' derived neuroblastoma cells ex vivo, BA may be a promising new agent for the treatment of neuroectodermal tumors in vivo.